KDIGO

The focused update of the KDIGO 2027 CKD Guideline is available for public review through November 4, 2026.

KDIGO invites the global kidney community to review the draft and share feedback to help inform and improve the final update.

Visit the KDIGO CKD Guideline website to download the draft and share your comments via the feedback survey:
kdigo.org/guidelines/ckd…

The focused update addresses new evidence since publication of the KDIGO 2024 CKD Guideline on SGLT2 inhibitors, GLP-1-based therapies, and nsMRAs in people with CKD, excluding those receiving dialysis or who have received a kidney transplant.

Thank you for your time and insights.

Check out the latest episode of the KDIGO Conversations in Nephrology podcast!

Listen to “Where Do Complement Inhibitors Fit in the IgAN Therapeutic Toolbox?” on your favorite podcast platform: kdigo.co/Convos-in-Neph…

In the third and final episode of KDIGO’s latest IgAN series, Dr. Brad Rovin, Co-Chair of the KDIGO IgAN Guideline, is joined by Dr. Sayna Norouzi to explore the evolving role of complement inhibitors in IgAN treatment.

The discussion examines patient selection, emerging clinical evidence, treatment duration, the role of kidney biopsy in guiding treatment decisions, and the potential for combining therapies targeting different disease mechanisms.

Listen to the full series: kdigo.co/Conversations-…

We are pleased to share the newest episode of the KDIGO Conversations in Nephrology podcast!

In Episode 35, the second in KDIGO’s latest three-part series on IgAN, Dr. Brad Rovin is joined by Dr. Andrew Bomback to explore which patients may benefit from complement inhibition and what information could help guide treatment selection.

Listen now on your favorite podcast platform: kdigo.co/Convos-in-Neph…

The discussion examines kidney biopsy findings, genetic testing, and emerging complement biomarkers, as well as practical lessons from treating C3 glomerulopathy, including vaccination, antibiotic prophylaxis, and multidisciplinary care.

There is still time to share your feedback! The focused update of the KDIGO 2027 CKD Guideline is available for public review through November 4, 2026.

Visit the KDIGO CKD Guideline website to download the draft and share your comments via the feedback survey: kdigo.org/guidelines/ckd…

The focused update addresses new evidence since publication of the KDIGO 2024 CKD Guideline on SGLT2 inhibitors, GLP-1-based therapies, and nsMRAs in people with CKD, excluding those receiving dialysis or who have received a kidney transplant.

Check out the latest issue of KDIGO Direct for news and updates from KDIGO: kdigo.co/KDIGO-Direct-O…

In this issue:

• Learn about KDIGO guideline methodology in a new series in @Kidney_Int

• Share feedback on the draft KDIGO 2027 CKD Guideline Update out for public review through November 4

• Take part in a new survey on C3G and aHUS

• Listen to the new IgAN episode of the KDIGO Conversations in Nephrology podcast

• Learn about upcoming KDIGO activities and events

• Explore new educational resources